The market for medical devices in China is predicted to reach $130 billion in 2020, with an annual growth rate of 11 percent from 2020 to 2025. This expansion will continue to be driven by the growing incidence of chronic diseases, rising healthcare expenditures due to income growth
Shanghai will create a “green route” to enable the importation of essential products. Liu Bo, deputy director of Shanghai Customs, said during a regular news conference on May 18 that Shanghai will create a “green route” for the city’s vital businesses, including integrated circuits, biopharmaceuticals, and automobile production.
The Chinese market for medical devices is substantial and expanding. In 2019, it recorded sales of RMB629 billion, up from RMB308 billion in 2015, representing a growth rate of almost twofold. Due to Covid-19, the demand for a variety of medical products
In recent years, drugs and medical devices are key industries related to national economy and people’s livelihood. China has launched a series of combination policies for reform and optimization, striving to improve the circulation efficiency of supply chain and reduce the circulation cost.
In the past April, BQ+ Medical experienced the challenges of simultaneous infection in Omicron, and was required to suspend production and quarantine. Now it has transferred to the closed production stage, and more employees are expected to return to work in May.
Since March 28, Chinese officials have imposed a lockdown on Shanghai’s more than 26 million residents, confining nearly all of them to their homes. This is the largest round of lockdown in Wuhan, China, since the COVID-19 outbreak in 2019.
BD (Becton, Dickinson and Firm) (NYSE: BDX), a leading worldwide medical technology company, said today that it was nominated to Fair Capital’s and CNBC’s JUST 100 list of America’s most just corporations.
Medically Home announced today that it has raised an additional $110 million in capital from key investors including Baxter International Inc., Global Medical Response (GMR), and Cardinal Health, each of whom will have a seat on the company’s board of directors.
January 6, 2022 – San Clemente, Calif. Smiths Medical has been acquired by ICU Medical Inc. (NASDAQ: ICUI) (LSE: SMIN.L). Smiths Medical’s portfolio of products includes syringe and ambulatory infusion devices, vascular access, and critical care.
DUBLIN, Ireland, December 22, 2021 /PRNewswire(opens new window)/ — Medtronic plc (NYSE:MDT), a worldwide leader in healthcare technology, said today that the Centers for Medicare & Medicaid Services (CMS) in the United States would extend Medicare coverage for all kinds of continuous glucose monitors (CGMs), including adjunctive and non-adjunctive CGMs.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical company, announced today that the BD VeritorTM At-Home COVID-19 Test is now available for purchase through Everly Health, a digital health company at the forefront of the virtual diagnostics-driven care industry, and Southeastern Grocers, the parent company of Fresco y Más, Harveys Supermarket, and Winn-Dixie stores.
